Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2024-09-09 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
关于参加广东辖区2024年投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an investor online collective reception day event organized by regulatory and industry bodies. It includes details about the event date, time, and participants from the company's management who will communicate with investors. There is no financial data, no report attached or referenced as being published, and no indication of a formal report or filing. The content focuses on investor relations and communication rather than a formal report or regulatory filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-09-09 Chinese
关于奋斗者一号员工持股计划锁定期届满的提示性公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the expiration of the lock-up period of an employee stock ownership plan. It details the background, the lock-up period, subsequent arrangements, and compliance with regulatory requirements. The document does not contain financial statements or detailed financial data, nor is it a report like an annual or interim report. It is a regulatory announcement about the status and next steps of an employee stock ownership plan, which fits best under the category of Regulatory Filings (RNS) as it is a compliance disclosure and does not fit other more specific categories.
2024-09-09 Chinese
关于公司产品获得欧盟MDR认证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about its products receiving EU Medical Devices Regulation (MDR) certification. It details the certification, product information, impact on the company, and risk warnings. The document is short (1431 characters) and does not contain financial data, earnings, or management discussion. It is not a report but an announcement of a regulatory approval related to product certification. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories like financial reports or management changes.
2024-09-03 Chinese
关于全资子公司取得新产品医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a subsidiary obtaining a new medical device registration certificate. It includes details about the product, registration number, validity, and potential impact on the company. There are no financial statements, earnings data, or detailed financial analysis. The document is short (1128 characters) and serves as an official announcement of a regulatory approval rather than a financial report or detailed management discussion. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is a regulatory announcement about a product certification, which aligns best with Regulatory Filings (RNS) as a general announcement category for miscellaneous filings that do not fit other specific categories.
2024-08-19 Chinese
监事会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 16th meeting of the 5th Supervisory Board of the company. It specifically mentions the approval of the company's 2024 semi-annual report and related summaries, but it does not contain the actual financial data or the full report itself. Instead, it refers readers to the full report published on an external website. The document also includes voting results for the resolutions. Given the document length (1094 characters) and the nature of the content (announcement of meeting resolutions and reference to the report rather than the report itself), this fits the category of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-08-07 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2024 年半年度报告摘要" which translates to "2024 Semi-Annual Report Summary." It contains detailed financial data such as revenue, net profit, cash flow, and other financial indicators for the half-year period. It also includes operational highlights, business segment performance, shareholder information, and corporate activities during the reporting period. The length of the document (12,295 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive interim report rather than a brief announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-07 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.